Holanek, M.; Selingerova, I.; Fabian, P.; Coufal, O.; Zapletal, O.; Petrakova, K.; Kazda, T.; Hrstka, R.; Poprach, A.; Zvarikova, M.;
et al. Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy. Diagnostics 2022, 12, 1740.
https://doi.org/10.3390/diagnostics12071740
AMA Style
Holanek M, Selingerova I, Fabian P, Coufal O, Zapletal O, Petrakova K, Kazda T, Hrstka R, Poprach A, Zvarikova M,
et al. Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy. Diagnostics. 2022; 12(7):1740.
https://doi.org/10.3390/diagnostics12071740
Chicago/Turabian Style
Holanek, Milos, Iveta Selingerova, Pavel Fabian, Oldrich Coufal, Ondrej Zapletal, Katarina Petrakova, Tomas Kazda, Roman Hrstka, Alexandr Poprach, Maria Zvarikova,
and et al. 2022. "Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy" Diagnostics 12, no. 7: 1740.
https://doi.org/10.3390/diagnostics12071740
APA Style
Holanek, M., Selingerova, I., Fabian, P., Coufal, O., Zapletal, O., Petrakova, K., Kazda, T., Hrstka, R., Poprach, A., Zvarikova, M., Bilek, O., & Svoboda, M.
(2022). Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy. Diagnostics, 12(7), 1740.
https://doi.org/10.3390/diagnostics12071740